Hensley Evans

Patients

Ask nearly any pharma company these days if they’re patient-centric, and you’ll probably get an answer in the affirmative.

News

Takeda and Protagonist's hepcidin mimetic rusfertide is the first hepcidin mimetic to be approved by the FDA for blood cancer polycythaemia vera.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.